“India, AstraZenekawa likely to approve two vaccines developed in-house”

Home> International> Asia and Australia





“India, AstraZenekawa likely to approve two vaccines developed in-house”

(Seoul = News 1) Reporter Choi Jong Il |
2021-01-03 08:38 sent

A new coronavirus infection (Corona 19) vaccine being jointly developed by British pharmaceutical company AstraZeneca and Oxford University © Reuters = News 1

Indian health authorities can approve a total of two COVID-19 vaccines jointly developed by British pharmaceutical companies AstraZeneca and Oxford University and vaccines developed by Barat Biotech in India, Reuters reported on the 2nd (local time), citing sources. .

Experts from the Indian Drug Administration (CDSCO) have already approved these two vaccines, and the final decision will be announced at a press conference on the 3rd.

According to the international statistics website World Omometer, as of 11 p.m. on the night of the 2nd, the cumulative confirmed cases of Corona 19 in India were 1032,4631, of which 141,9471 died.

[email protected]







Source